Michigan Attorney General Dana Nessel has filed a landmark lawsuit against Blue Cross Blue Shield of Michigan, alleging the insurer operated an illegal monopoly that violated state and federal antitrust and consumer protection laws. The suit, filed on October 8 in U.S. District Court in Detroit, claims that Blue Cross’s control of approximately 65% of Michigan’s commercial health insurance market and 79% of preferred provider organization plans has stifled competition, driven up premiums, and limited reimbursements to medical providers.
Nessel’s complaint portrays a coordinated effort by Blue Cross and the broader Blue Cross Blue Shield network to restrict competition through anti-competitive agreements that allocated customers and territories, curtailed product offerings, and maintained market dominance by means other than superior products or marketing. The attorney general argues that this dominance allowed the company to push payment rates to health care providers near or below their costs while simultaneously increasing charges to consumers.
The lawsuit contends that Michigan’s health insurance market ranks among the least competitive nationally, contributing to rising premiums and reduced access to care. In 2026, Blue Cross sought premium increases of up to 24% for individual plans and over 11% for small group policies. Medical providers have faced increasingly low reimbursements, leading to financial difficulties including hospital closures such as that of Sturgis Hospital in June, which the suit attributes to insufficient insurance payments. According to court documents, these dynamics have also contributed to worsening health outcomes, including Michigan’s infant mortality rate.
The lawsuit charges Blue Cross with multiple violations, including two counts under the federal Sherman Antitrust Act, four counts under the Michigan Antitrust Reform Act, and additional claims of public nuisance and unjust enrichment. It seeks damages estimated in the hundreds of millions of dollars and injunctive relief to prevent future anti-competitive conduct.
Blue Cross responded to the filing by stating that it had not been formally served and declined to comment on the case’s merits. The insurer also disputed the characterization of the Michigan insurance market as uncompetitive, emphasizing ongoing competition from local and national insurers. The company has posted underwriting losses for five consecutive years, reporting a $246 million net loss in 2025 on revenue of $43.3 billion while continuing to raise premiums substantially for some customers.
The lawsuit highlights real-world consequences for Michigan families, including the case of Jibran Bashi, a Detroit infant born with an extremely rare heart defect. His parents, Andrew and Amanda Bashi, initially sought care from Michigan Medicine, whose multidisciplinary team was uniquely qualified to treat Jibran. However, a contract dispute between Blue Cross and Michigan Medicine endangered in-network coverage for roughly 300,000 insured individuals. The disagreement centered on Blue Cross’s refusal to increase reimbursement rates, citing cost controls to limit premiums, while Michigan Medicine maintained that higher payments were necessary to sustain specialized care.
The Bashis described the intense financial and emotional strain caused by the dispute, expressing relief only after the parties reached a resolution. Andrew Bashi characterized the lawsuit as a necessary measure to address the consequences of concentrated market power in health care, underscoring broader concerns about a system focused more on profits than patient outcomes. He argued that while legal action is crucial, long-term solutions require health care models centered on results rather than revenue.